SRPT logo

Sarepta Therapeutics (SRPT) Total expenses

Annual total expenses:

$1.68B+$172.74M(+11.43%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SRPT annual total expenses is $1.68 billion, with the most recent change of +$172.74 million (+11.43%) on December 31, 2024.
  • During the last 3 years, SRPT annual total expenses has risen by +$532.30 million (+46.22%).
  • SRPT annual total expenses is now at all-time high.

Performance

SRPT Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

Quarterly total expenses:

$1.05B+$548.51M(+110.42%)
March 1, 2025

Summary

  • As of today (May 29, 2025), SRPT quarterly total expenses is $1.05 billion, with the most recent change of +$548.51 million (+110.42%) on March 1, 2025.
  • Over the past year, SRPT quarterly total expenses has increased by +$666.68 million (+176.11%).
  • SRPT quarterly total expenses is now at all-time high.

Performance

SRPT Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

SRPT Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+11.4%+176.1%
3 y3 years+46.2%+251.1%
5 y5 years+86.5%+351.1%

SRPT Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+46.2%at high+251.1%
5 y5-yearat high+86.5%at high+366.9%
alltimeall timeat high>+9999.0%at high>+9999.0%

SRPT Total expenses History

DateAnnualQuarterly
Mar 2025
-
$1.05B(+110.4%)
Dec 2024
$1.68B(+11.4%)
$496.73M(+11.6%)
Sep 2024
-
$444.98M(+22.4%)
Jun 2024
-
$363.63M(-3.9%)
Mar 2024
-
$378.56M(+1.7%)
Dec 2023
$1.51B(+2.9%)
$372.16M(+5.5%)
Sep 2023
-
$352.66M(-10.7%)
Jun 2023
-
$394.76M(+0.8%)
Mar 2023
-
$391.59M(+7.2%)
Dec 2022
$1.47B(+27.6%)
$365.26M(+1.0%)
Sep 2022
-
$361.62M(-18.7%)
Jun 2022
-
$444.62M(+49.3%)
Mar 2022
-
$297.71M(-3.1%)
Dec 2021
$1.15B(+4.3%)
$307.27M(+37.3%)
Sep 2021
-
$223.86M(-32.5%)
Jun 2021
-
$331.66M(+14.8%)
Mar 2021
-
$288.80M(-8.6%)
Dec 2020
$1.10B(+22.3%)
$315.85M(+12.4%)
Sep 2020
-
$280.99M(+1.9%)
Jun 2020
-
$275.72M(+19.0%)
Mar 2020
-
$231.70M(-27.7%)
Dec 2019
$903.16M(+40.1%)
$320.33M(+43.9%)
Sep 2019
-
$222.63M(+13.1%)
Jun 2019
-
$196.79M(+20.4%)
Mar 2019
-
$163.40M(-26.2%)
Dec 2018
$644.66M(+116.5%)
$221.56M(+49.1%)
Sep 2018
-
$148.59M(-17.1%)
Jun 2018
-
$179.18M(+87.9%)
Mar 2018
-
$95.34M(+14.9%)
Dec 2017
$297.80M(+10.5%)
$83.01M(+25.3%)
Sep 2017
-
$66.27M(-28.8%)
Jun 2017
-
$93.09M(+67.5%)
Mar 2017
-
$55.59M(-39.5%)
Dec 2016
$269.60M(+21.8%)
$91.91M(+62.6%)
Sep 2016
-
$56.53M(-8.8%)
Jun 2016
-
$61.98M(+3.8%)
Mar 2016
-
$59.70M(-9.1%)
Dec 2015
$221.44M(+54.3%)
$65.70M(+26.9%)
Sep 2015
-
$51.76M(+22.9%)
Jun 2015
-
$42.11M(-31.9%)
Mar 2015
-
$61.86M(+38.2%)
Dec 2014
$143.55M(+37.4%)
$44.75M(+28.8%)
Sep 2014
-
$34.73M(+5.7%)
Jun 2014
-
$32.85M(+5.3%)
Mar 2014
-
$31.21M(-12.0%)
Dec 2013
$104.50M(+55.9%)
$35.48M(+21.9%)
Sep 2013
-
$29.10M(+45.2%)
Jun 2013
-
$20.04M(+0.7%)
Mar 2013
-
$19.89M(+12.3%)
Dec 2012
$67.03M(-19.2%)
$17.70M(+22.3%)
Sep 2012
-
$14.48M(-13.6%)
Jun 2012
-
$16.76M(-7.3%)
Mar 2012
-
$18.09M(-19.9%)
Dec 2011
$82.92M(+64.7%)
$22.59M(+20.2%)
Sep 2011
-
$18.80M(-13.4%)
Jun 2011
-
$21.71M(+9.5%)
Mar 2011
-
$19.83M(+14.9%)
DateAnnualQuarterly
Dec 2010
$50.35M(+52.2%)
$17.26M(+38.1%)
Sep 2010
-
$12.50M(+7.2%)
Jun 2010
-
$11.66M(+30.5%)
Mar 2010
-
$8.94M(-1.7%)
Dec 2009
$33.09M(-14.7%)
$9.10M(-1.9%)
Sep 2009
-
$9.27M(+15.8%)
Jun 2009
-
$8.01M(+19.3%)
Mar 2009
-
$6.71M(-19.8%)
Dec 2008
$38.80M(-12.0%)
$8.37M(-24.6%)
Sep 2008
-
$11.11M(+12.6%)
Jun 2008
-
$9.86M(+4.3%)
Mar 2008
-
$9.46M(-12.9%)
Dec 2007
$44.09M(+33.2%)
$10.85M(-5.0%)
Sep 2007
-
$11.43M(+2.1%)
Jun 2007
-
$11.19M(+5.4%)
Mar 2007
-
$10.62M(+20.8%)
Dec 2006
$33.10M(+48.4%)
$8.79M(+20.6%)
Sep 2006
-
$7.29M(-2.0%)
Jun 2006
-
$7.44M(-22.4%)
Mar 2006
-
$9.59M(+51.6%)
Dec 2005
$22.30M(-12.5%)
$6.32M(+21.6%)
Sep 2005
-
$5.20M(+0.2%)
Jun 2005
-
$5.19M(-7.2%)
Mar 2005
-
$5.59M(+7.0%)
Dec 2004
$25.47M(+28.4%)
$5.22M(+1.8%)
Sep 2004
-
$5.13M(-29.4%)
Jun 2004
-
$7.27M(-7.4%)
Mar 2004
-
$7.85M(+7.7%)
Dec 2003
$19.84M(-24.2%)
$7.29M(+43.2%)
Sep 2003
-
$5.09M(+37.1%)
Jun 2003
-
$3.72M(-0.6%)
Mar 2003
-
$3.74M(-13.5%)
Dec 2002
$26.18M(+62.5%)
$4.32M(-22.9%)
Sep 2002
-
$5.60M(-31.0%)
Jun 2002
-
$8.12M(-0.2%)
Mar 2002
-
$8.13M(+61.8%)
Dec 2001
$16.11M(+39.6%)
$5.03M(+37.6%)
Sep 2001
-
$3.65M(-5.7%)
Jun 2001
-
$3.87M(+8.9%)
Mar 2001
-
$3.56M(+2.2%)
Dec 2000
$11.54M(+37.4%)
$3.48M(+28.2%)
Sep 2000
-
$2.71M(-8.8%)
Jun 2000
-
$2.97M(+25.4%)
Mar 2000
-
$2.37M(-1.1%)
Dec 1999
$8.40M(+6.3%)
$2.40M(+9.1%)
Sep 1999
-
$2.20M(+10.0%)
Jun 1999
-
$2.00M(+17.6%)
Mar 1999
-
$1.70M(-34.6%)
Dec 1998
$7.90M(+97.5%)
$2.60M(+36.8%)
Sep 1998
-
$1.90M(+5.6%)
Jun 1998
-
$1.80M(+12.5%)
Mar 1998
-
$1.60M(+60.0%)
Dec 1997
$4.00M(+73.9%)
$1.00M(0.0%)
Sep 1997
-
$1.00M(-23.1%)
Jun 1997
-
$1.30M(+85.7%)
Mar 1997
-
$700.00K
Dec 1996
$2.30M
-

FAQ

  • What is Sarepta Therapeutics annual total expenses?
  • What is the all time high annual total expenses for Sarepta Therapeutics?
  • What is Sarepta Therapeutics annual total expenses year-on-year change?
  • What is Sarepta Therapeutics quarterly total expenses?
  • What is the all time high quarterly total expenses for Sarepta Therapeutics?
  • What is Sarepta Therapeutics quarterly total expenses year-on-year change?

What is Sarepta Therapeutics annual total expenses?

The current annual total expenses of SRPT is $1.68B

What is the all time high annual total expenses for Sarepta Therapeutics?

Sarepta Therapeutics all-time high annual total expenses is $1.68B

What is Sarepta Therapeutics annual total expenses year-on-year change?

Over the past year, SRPT annual total expenses has changed by +$172.74M (+11.43%)

What is Sarepta Therapeutics quarterly total expenses?

The current quarterly total expenses of SRPT is $1.05B

What is the all time high quarterly total expenses for Sarepta Therapeutics?

Sarepta Therapeutics all-time high quarterly total expenses is $1.05B

What is Sarepta Therapeutics quarterly total expenses year-on-year change?

Over the past year, SRPT quarterly total expenses has changed by +$666.68M (+176.11%)
On this page